| Join Now
A workshop on Bayesian adaptive randomised trials, delivered by international leaders in this field; Dr Lorenzo Trippa and Dr Steffen Ventz.
Adaptive clinical trial designs have proven valuable to accelerate the development of new treatments. Adaptive randomisation based on Bayesian principles has been proposed for testing several treatments in complex clinical trials on heterogeneous populations.
Recent applications suggest that outcome adaptive approaches can accelerate drug development processes. Adaptive algorithms attempt to learn and identify, during the trial, the best available treatment options for individual patients enrolled in the trial.
For more information, please click here.
Statistical Society of Australia
PO Box 213
Belconnen ACT 2616 Australia
02 6251 3647www.statsoc.org.auABN 82 853 491 081
Please direct enquiries to:
Marie-Louise Rankin, Executive Officer
© 2019 Statistical Society of Australia. All Rights Reserved. | website login
Website by Converge Design